Loading...
Levodopa in Parkinson’s Disease: Current Status and Future Developments
BACKGROUND: Ever since the pioneering reports in the 60s, L-3,4-Dioxyphenylalanine (levodopa) has represented the gold standard for the treatment of Parkinson’s Disease (PD). However, long-term levodopa (LD) treatment is frequently associated with fluctuations in motor response with serious impact o...
Saved in:
| Published in: | Curr Neuropharmacol |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Bentham Science Publishers
2018
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6187751/ https://ncbi.nlm.nih.gov/pubmed/28494719 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2174/1570159X15666170510143821 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|